You just read:

CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery

News provided by

CytoSorbents Corporation

May 12, 2020, 07:08 ET